Edition:
United States

Insider Trading: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

25.28USD
29 Jul 2016
Change (% chg)

$0.33 (+1.32%)
Prev Close
$24.95
Open
$24.60
Day's High
$25.47
Day's Low
$24.24
Volume
728,949
Avg. Vol
605,910
52-wk High
$43.63
52-wk Low
$23.85

COHEN RON

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 263
Total Shares Held: 47,550,916
3 Mo. Net Change: -196,006
# New Positions: 3
# Closed Positions: 12
# Increased Positions: 22
# Reduced Positions: 20
# Net Buyers: 2

Officers & Directors

Name Age Since Current Position

Ron Cohen

60 President,Chief Executive Officer, Director

Michael Rogers

56 2013 Chief Financial Officer

Andrew Blight

64 2004 Chief Scientific Officer

Jane Wasman

60 2012 President - International, General Counsel, Corporate Secretary

Burkhard Blank

60 2016 Chief Medical Officer

Andrew Hindman

42 2014 Chief Business Development Officer

David Lawrence

57 2013 Chief - Business Operations

Lauren Sabella

54 2015 Chief Commercial Officer

Barry Greene

52 2007 Independent Director

Peder Jensen

60 2011 Independent Director

John Kelley

62 2008 Independent Director

Sandra Panem

68 1998 Independent Director

Lorin Randall

72 2006 Independent Director

Steven Rauscher

61 2005 Independent Director

Ian Smith

50 2007 Independent Director